Logo image
Prevention and diagnosis of severe T-Cell-Mediated adverse drug reactions: Are we there yet?
Journal article   Peer reviewed

Prevention and diagnosis of severe T-Cell-Mediated adverse drug reactions: Are we there yet?

A. Redwood, J. Trubiano and E. Phillips
Journal of Allergy and Clinical Immunology: In Practice, Vol.7(1), pp.228-230
2018
url
Link to Published Version *Subscription may be requiredView

Abstract

Severe cutaneous adverse reactions (SCARs), such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS), are T-cell-mediated delayed reactions that are associated with significant short-term morbidity and mortality...

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.265 Dermatology - Skin Allergies
1.265.1140 Drug Hypersensitivity
Web Of Science research areas
Allergy
Immunology
ESI research areas
Clinical Medicine
Logo image